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ROCK signaling causes epidermal hyper-prolifera-
tion by increasing ECM production, elevating dermal
stiffness, and enhancing Fak-mediated mechano-
transduction signaling. Elevated dermal stiffness in
turn causes ROCK activation, establishing me-
chano-reciprocity, a positive feedback loop that
can promote tumors. We have identified a negative
feedback mechanism that limits excessive ROCK
signaling during wound healing and is lost in squa-
mous cell carcinomas (SCCs). Signal flux through
ROCK was selectively tuned down by increased
levels of 14-3-3z, which interacted with Mypt1, a
ROCK signaling antagonist. In 14-3-3z/mice, unre-
strained ROCK signaling at wound margins elevated
ECM production and reduced ECM remodeling,
increasing dermal stiffness and causing rapid wound
healing. Conversely, 14-3-3z deficiency enhanced
cutaneous SCC size. Significantly, inhibiting 14-3-
3z with a novel pharmacological agent accelerated
wound healing 2-fold. Patient samples of chronic
non-healing wounds overexpressed 14-3-3z, while
cutaneous SCCs had reduced 14-3-3z. These results
reveal a novel 14-3-3z-dependent mechanism that
negatively regulates mechano-reciprocity, suggest-
ing new therapeutic opportunities.
INTRODUCTION
The significance of mechanical force in regulating skin homeo-
stasis is becoming increasingly evident and has important impli-
cations for human health (Wong et al., 2012). However, the
molecular mechanisms underlying the interplay between me-
chanical force and cell signaling are poorly understood. A keyDevelopmeconcept of tissue biology is that increased extra-cellular matrix
(ECM) stiffness causes mitogenic signaling that promotes cell
proliferation and RhoA activation, or outside-in mechanical
signaling (Butcher et al., 2009). Conversely, activation of
ROCK, a serine/threonine kinase and the major effector protein
of RhoA, causes epidermal proliferation by promoting ECM pro-
duction and increasingmatrix stiffness, or inside-out mechanical
signaling (Ibbetson et al., 2013; Samuel et al., 2011a). These two
signaling paradigms, termed mechano-reciprocity, balance tis-
sue and cell level forces against each other to maintain tissue
and cell integrity. The Rho-ROCK signaling pathway therefore
lies at the interface between mechanical and biochemical
signaling in skin and other tissues, including mammary (Calvo
et al., 2013), ovary (McGrail et al., 2014), and intestine (Haydont
et al., 2007). In cutaneous squamous cell carcinoma (SCC), me-
chano-reciprocity causes a vicious cycle of ever escalating ECM
stiffness, ROCK pathway activation, and uncontrolled cell prolif-
eration (Ibbetson et al., 2013; Samuel et al., 2011a). However,
during normal re-epithelialization, such as wound healing, re-es-
tablishing mechano-reciprocity does not cause uncontrolled cell
proliferation, suggesting that negative regulators are deployed
under such conditions.
ROCK signaling establishes and regulates the contractility of a
trans-cellular actomyosin ring at the wound margin (termed the
purse-string mechanism) in the late stage of wound healing
(Cowin et al., 2003). However, given the fundamental role of
ROCK signaling in ECM homeostasis, it likely functions
throughout wound healing in re-establishing mechano-reci-
procity, not just in the final stages. Indeed, the re-establishment
of mechano-reciprocity has been proposed as a key mechanism
guiding wound healing (Schultz et al., 2011), but definitive proof
has remained elusive.
14-3-3z belongs to a family of highly conserved, acidic, phos-
pho-serine binding proteins (b, g, ε, s, z, t, and h) (Ichimura et al.,
1988; Toker et al., 1992) that are key players inmany cellular pro-
cesses (Aitken, 2006). Whereas 14-3-3 proteins share consider-
able sequence homology at the protein level and are thought to
act redundantly, there is increasing evidence for non-redundantntal Cell 35, 759–774, December 21, 2015 ª2015 Elsevier Inc. 759
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Figure 1. 14-3-3z Mice Exhibit Abnormal Epidermal Homeostasis and Rapid Wound Healing
(A and B) Bright-field image of H&E-stained sections of WT and 14-3-3z KO skin treated with either vehicle or TPA (A). Epidermal thickness measurements are
shown in (B). The scale bar represents 100 mm.
(C) Regression analysis of wound width over time in WT (black circles and line) and 14-3-3z KO (blue squares and line) skin. Dotted lines indicate half-times. See
Figure S1D for representative images used for measurements.
(D) 14-3-3z immunofluorescence (white in single channel, red in merged) in wounds, wound margins (day 5), and intact skin of WT mice. D, dermis; E, epidermis.
The scale bars represent 100 mm.
(E) qRT-PCR analysis of 14-3-3z mRNA in wounded (day 5) and unwounded skin of WT mice relative to 18S. N = 5.
(legend continued on next page)
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functions for individual family members (Cheah et al., 2012;
Uhart and Bustos, 2013).
Using mice deficient in 14-3-3z and mice expressing condi-
tionally active ROCK, we have revealed a mechanism that
moderates mechano-reciprocity, regulates wound healing, and
prevents the positively reinforcing cycle of intra- and extra-
cellular forces that promotes tumor progression.
RESULTS
14-3-3z Knockout Mice Exhibit Perturbed Epidermal
Homeostasis and Accelerated Wound Healing
Optimal balance of cell- and tissue-level forces is needed for tis-
sue homeostasis (Butcher et al., 2009). The skin is exquisitely
sensitive to changes in force (Wang et al., 2015). We have previ-
ously shown that the balance of extra- and intra-cellular forces is
regulated by ROCK signaling and that enhanced mechano-
reciprocal forces result in large changes in epidermal thickness
(Samuel et al., 2011a). Intriguingly histological analysis of skin bi-
opsies from 14-3-3z wild-type (WT) and 14-3-3z-deficient
(knockout [KO]) mice revealed that KO mice exhibited an
15% thinner epidermal layer than WT mice (Figures 1A and
1B), and this differential was enhanced to >30% upon epidermal
hyper-proliferation induced by topical application of 12-O-tetra-
decanoylphorbol-13-acetate (TPA), a protein kinase C activator
(Niedel et al., 1983) (Figures 1A and 1B). 14-3-3z gene-targeted
mice had no 14-3-3z protein (Figures S1A and S1B) or mRNA
(Figure S1C) in the skin and other 14-3-3 isoforms were not
differentially regulated in 14-3-3z KO skin (Figure S1C), suggest-
ing that 14-3-3z has a non-redundant function in epidermal
homeostasis.
Because a thin epidermis is reminiscent of impaired mechan-
ical signaling (Samuel and Olson, 2011) in 14-3-3z KO skin, we
explored if 14-3-3z has a role in re-establishing normal me-
chano-reciprocity during wound repair, using the incisional
wound healing model (Lees et al., 2013). 14-3-3z KO mice ex-
hibited >2.5-fold faster wound healing compared with WT mice
(Figures 1C, S1D, and S1E), with regression analysis showing
that the median wound healing time was 2.4 days in 14-3-3z
KO mice compared with 6.6 days in WT littermates (Figure 1C).
At wound margins in WT mice, 14-3-3zmRNA and protein levels
were elevated compared with those in unwounded WT skin (Fig-
ures 1D and 1E), but other isoforms of 14-3-3 were not (Fig-
ure S1F), suggesting that 14-3-3z has a specific function in
wound healing.
To determine if healing of KO wounds was promoted by an in-
crease in dermal fibroblasts, which re-establish the dermal ECM
and provide contractile force for wound closure (Driskell and
Watt, 2015), we performed immunofluorescence analysis for
S100A4/Fsp1 (fibroblast marker; Figure 1F) and a-smooth mus-
cle actin (SMA) (a transient myofibroblast-specific marker; Fig-
ure S1G) (Darby et al., 1990) in wounded and unwounded skin
but found no differences in the numbers of these cells in the(F) S100A4 immunofluorescence (white in single channel, red in merged) in unwo
The scale bars represent 100 mm.
(G) Western analysis of paxillin and SMA in primary dermal fibroblasts cultured un
starvation (SS) as described in Experimental Procedures.
See also Figure S1.
Developmetwo genotypes at any point in wound healing. Furthermore,
SMA levels were comparable in primary dermal fibroblasts
from 14-3-3z KO and WT mice (Figure 1G; quantified in Fig-
ure S1H). These data suggested that rapid wound healing in
14-3-3z KO skin was not driven by an increased number of
dermal fibroblasts or myofibroblasts.
Rapid Wound Healing in 14-3-3z KO Mice Is Associated
with Changes in ECM Composition
Normal wound re-epithelialization is dependent on re-establish-
ing the dermis, which comprises ECM populated by dermal
fibroblasts and immune cells (Bainbridge, 2013). Dermal fibro-
blasts produce and remodel the fibrillar ECM proteins (Toma-
sek et al., 2002). We hypothesized that differences in ECM
composition and resulting differences in extra-cellular force
may influence wound healing in 14-3-3z KO skin. We therefore
analyzed collagen composition and remodeling at wound mar-
gins by second harmonic generation (SHG) microscopy (Ibbet-
son et al., 2013; Samuel and Olson, 2011). Area coverage
analysis of SHG images revealed more collagen at wound mar-
gins in 14-3-3z KO skin compared with WT skin at the protein
level (Figures 2A and 2B; see also the schematic for wound
imaging in Figure S2A), consistent with mRNA expression
data (Figure S2B). Furthermore, collagen fibers at 14-3-3z KO
wound margins appeared less organized than at WT wound
margins and lacked the uniformly bundled, parallel structures
characteristic of normal dermal collagen (Figure 2A, insets).
Accordingly, gray-level co-occurrence matrix (GLCM) analysis
performed on SHG images of WT and 14-3-3z KO mice
7 days after wounding showed that collagen fibers at 14-3-3z
KO wound margins have a significantly slower signal decay
than in fibers in WT wounds (Figures 2C and S2C), suggesting
that 14-3-3z KO wounds have a denser, un-remodeled collagen
matrix than WT wounds. Similarly, increased levels of two other
ECM proteins, periostin (Figures 2D and S2D) and tenascin-C
(Figures 2E and S2E), were observed in 14-3-3z KO skin
compared with WT skin. All three proteins have established
functions in tissue regeneration (Kudo, 2011; Midwood et al.,
2011). Interestingly, collagen (Figure S2F) and periostin (Fig-
ure S2G) levels were similar in unwounded 14-3-3z KO and
WT skin, and tenascin-C (Figure S2H) was undetectable in un-
wounded skin of either genotype. Taken together, these results
show that 14-3-3z deficiency increased ECM production and
impaired remodeling at wound margins.
Signaling Downstream of ROCK Is Hyper-activated at
Wound Margins in 14-3-3z KO Mice
ROCK activation at cutaneous wound margins regulates the as-
sembly and contraction of an actin ring, which facilitates wound
closure at the late stages of wound healing (Russo et al., 2005).
However, we have also previously shown that ROCK signaling
in keratinocytes regulates the production of several ECM pro-
teins strongly linked to mechanical signaling in the dermisunded skin and day 5 wounds of 14-3-3z KO and WT mice. S, scar; W, wound.
der steady-state conditions (St), starved of serum (Sv), or stimulated following
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Figure 2. Rapid Wound Healing in 14-3-3z KO Mice Is Associated with Changes in ECM Composition and Increased ROCK Signaling
(A and B) Dual two-photon SHG and monochromatic transmission (Trans; grayscale in merge) images showing collagen (white in single channel, magenta in
merged) around day 7 wound margins (dotted lines) in H&E-stained WT and 14-3-3z KO skin sections (A). Yellow boxes are magnified in insets. Area coverage
analysis (10 fields/sample from five mice/genotype) of SHG is quantified in (B).
(C) GLCM analysis of SHG images from WT and 14-3-3z KO day 7 wound margins, with signal homogeneity plotted against distance from each reference pixel.
Dashed lines show the non-linear bi-exponential fit to each data set. Error bars indicate SEM. Regions analyzed are shown in Figure S2. Inset shows the mean
decay parameter (slope) of the bi-exponential fit model of correlation decay curve for samples of each genotype. N = 10.
(legend continued on next page)
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(Ibbetson et al., 2013). We hypothesized that ROCK activation
at wound margins may also have a role in regulating dermal
ECM regeneration and therefore assessed ROCK activation at
wound margins in WT and 14-3-3z KO mice by confocal immu-
nofluorescence analysis of the myosin phosphatase target sub-
unit 1 phosphorylated (pMypt1) at the ROCK target site Thr-696
(Feng et al., 1999). To delineate the epidermis, we used the ker-
atinocyte marker cytokeratin 14 (CK14). WT mice exhibit a
broad band of moderately elevated pMypt1 close to the
wound, whereas KO mice exhibit greatly increased pMypt1 at
wound margins compared with WT mice throughout the healing
process (Figures 2F and 2G). Baseline pMypt1 levels measured
5 mm from the wound edge (Figure 2G) were comparable in
both genotypes and similar to those observed under un-
wounded, steady-state conditions (Figure S2I). Because
Mypt1 may also be phosphorylated by other Rac-effector pro-
teins such as Mrck (Wilkinson et al., 2005), we sought to
confirm differential ROCK activation in WT and 14-3-3z KO
cells in vitro. To that end, we derived primary dermal fibroblasts
and keratinocytes from WT and 14-3-3z KO mice and validated
these by fibroblast- and keratinocyte-specific markers,
S100A4/Fsp1 and CK14, respectively (Figure S2J). When pri-
mary keratinocytes of both genotypes seeded at low density
were starved and then treated with 50 ng/ml EGF for 1 hr
(time selected by analyzing the time course of signaling; Fig-
ure S2K) to stimulate Rho-ROCK pathway activation, 14-3-3z
KO keratinocytes exhibited significantly increased stress fiber
formation compared with WT (Figure 2H and Figure S2L, in-
sets). Mlc2 is activated by Thr-18/Ser-19 di-phosphorylation
by ROCK (Amano et al., 1996). We observed increased phos-
phorylation of regulatory myosin light chain (pMlc2; Figure 2I)
localized to stress fibers in 14-3-3z KO keratinocytes compared
with WT keratinocytes (Figure 2H and Figure S2L, inset).
Together, these data suggest that signaling through ROCK is
enhanced in 14-3-3z KO compared with WT keratinocytes un-
der identical conditions that cause signaling through this
pathway, at wound margins and in vitro.
Increased SignalingDownstreamof ROCKat 14-3-3zKO
Wound Margins Accelerates Re-epithelialization by
Enhancing Mechano-transduction Signaling
To determine if enforced ROCK activation at wound margins is
capable of accelerating re-epithelialization, we used a mouse
model (K14-ROCK:ER) that we previously generated, in which
ROCK may be conditionally activated in the epidermis by
topical application of 4-hydroxytamoxifen (4HT) (Samuel
et al., 2009a). Upon ROCK activation at wound margins of
K14-ROCK:ER mice, re-epithelialization was accelerated(D and E) Quantification of periostin (D) and tenascin-C (E) at day 7 WT and 14-
rescence on tissues from four mice/genotype, 10–12 fields/mouse. Representat
(F) Representative confocal immunofluorescence analysis of phospho-Thr-696m
KO and WT wound margins. Tracks used for line scans in (G) are shown in red. T
(G) A representative line scan of p(Thr-696)Mypt1 immunofluorescence derived
distance from margin (solid lines). Mean fluorescence intensity (dotted lines) and
(H) Confocal immunofluorescence analysis of cultured primary 14-3-3z KO andW
complete keratinocyte growth medium supplemented with 50 ng/ml EGF for 1 h
phosphorylated at Ser-19 (pMlc2, green). Red inset is magnified. The scale bar r
(I) Western analysis of pp(Thr-18/Ser-19)-Mlc2 in cultured primary keratinocytes
represent pMlc2 bands intensities normalized to total Mlc.
Developmecompared with that in K14-KD:ER control mice that express ki-
nase-dead ROCK (Figure 3A), in a statistically significant
manner comparable with that observed in 14-3-3z KO relative
to WT wounds. Accelerated wound healing in K14-ROCK:ER
mice was accompanied by increased collagen (Figure 3B), peri-
ostin, and tenascin C (Figure 3C) production compared with
that in K14-KD:ER mice, very reminiscent of our observations
in 14-3-3z KO versus WT wounds (Figures 2A, 2B, 2D, and
2E). Taken together with our previous reports that ROCK-medi-
ated ECM deposition and remodeling induces epidermal cell
proliferation (Samuel et al., 2011a), these data strongly suggest
that ROCK-mediated ECM production is increased in 14-3-3z
KO wounds.
Because elevated collagen density is associated in many tis-
sues with increased outside-in mechanical signaling mediated
by integrin ligation (Egeblad et al., 2010), we next assessed
Fak auto-phosphorylation at Tyr-397, a known early response
to increased ECM density (Assoian and Klein, 2008). p(Tyr-
397)Fak levels were elevated in re-epithelializing K14-ROCK:ER
wounds compared with those in K14-KD:ER control wounds
(Figure 3D, top panels), strongly suggesting that outside-in me-
chanical signaling was enhanced under conditions of ROCK
activation. Similarly, p(Tyr-397)Fak was also elevated at 14-3-
3z KO wound margins compared with WT margins (Figure 3E,
top panels; quantified in Figure 3F), suggesting that outside-in
mechanical signaling was enhanced when 14-3-3z was absent.
Furthermore, we also observed increased levels of (active)
p(Ser-473)Akt in K14-ROCK:ER wounds (Figure 3D, bottom
panels) and 14-3-3z KO wounds (Figure 3E, bottom panels)
compared with K14-KD:ER and WT wounds, respectively,
consistent with the activation of mechano-transduction path-
ways downstream of integrin activation (Tian et al., 2002).
These data show that when 14-3-3z is absent, the mechano-
transduction signaling pathway downstream of integrins and
FAK are hyper-activated at wound margins, in a similar manner
to that in ROCK-activated wounds.
Together with our previous observations that the collagen/
integrin/FAK/PI3K/AKT pathway enhances epidermal prolif-
eration (Samuel et al., 2011a), our new data reveal that 14-3-3z
has a fundamental role in epidermal homeostasis and wound
healing by negatively regulating mechano-reciprocity through a
mechanism that inhibits inside-out mechano-transduction
signaling pathways mediated by ROCK.
To determine if enhanced signaling through ROCK was
responsible for accelerated wound healing in 14-3-3z KO mice,
we adopted a pharmacological approach, topically applying
the selective ROCK inhibitor Y-27632 or vehicle to the wound
margins (25 mg/mouse once daily for 5 days) of cohorts of3-3z KO wound margins by integrated density measurements of immunofluo-
ive images: Figures S2D and S2E.
yosin phosphatase (pMypt, white in single channel, green in merged) at 14-3-3z
he scale bar represents 100 mm.
from a WT and a 14-3-3z KO wound, showing fluorescence intensity versus
fluorescence at a distal site, 5 mm from the wound are also shown (n = 5).
T keratinocytes, starved in serum-free DMEM or starved and then incubated in
r, showing actin stress fibers (Actin, red) and co-localized myosin light chain
epresents 100 mm. See also Figure S2L.
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Figure 3. Outside-In Mechano-transduction Signaling Is Enhanced at 14-3-3z KO Wound Margins and Is Dependent on ROCK Activity
(A) Wound widths at day 7 following wounding in K14-KD:ER and K14-ROCK:ER mice (four mice/genotype) topically treated daily with 4HT. N = 5.
(B) Two-photon SHGmicroscopy of collagen (white in single channel, magenta in merged) with co-acquired transmission image (Trans) of H&E-stained sections
of K14-KD:ER and K14-ROCK:ER wound margins. The scale bars represent 100 mm.
(C) Confocal immunofluorescence analysis of periostin (Peri; green) and tenascin-C (Ten C; red) at day 7 K14-KD:ER and K14-ROCK:ER wound margins. The
scale bars represent 100 mm.
(D) Confocal immunofluorescence analysis of pFak (top six panels: white in single channel, green in merged) and pAkt (bottom six panels: white in single channel,
green in merged) at day 7 K14-KD:ER and K14-ROCK:ER wound margins. CK14 denotes epidermal layer. The scale bars represent 100 mm.
(legend continued on next page)
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14-3-3z KO mice. ROCK inhibition completely abolished accel-
erated wound healing in 14-3-3zKOmice (Figure 3G) and greatly
reduced collagen production at wound margins (Figure S3A).
These data show that the accelerated wound healing in 14-3-
3z KO mice is likely mediated by enhanced ECM-initiated
mechano-transduction signaling caused by increased ROCK
activation at wound margins.
Dermal fibroblasts are the cells mainly responsible for produc-
ing ECM proteins (Tomasek et al., 2002). Media conditioned
in vitro by ROCK-activated K14-ROCK:ER keratinocytes,
induced collagen 1a and 3a mRNA in WT dermal fibroblasts,
whereas media conditioned by K14-KD:ER-derived primary ker-
atinocytes did not (Figures 3H and S3B), suggesting that ROCK
activation in keratinocytes stimulates collagen production by fi-
broblasts by a paracrine mechanism. Similarly, media condi-
tioned by 14-3-3z KO primary keratinocytes subjected to serum
starvation followed by serum stimulation induced >2-fold more
transcription of collagen 1a and 3a in primary dermal fibroblasts
compared with media conditioned in the same manner by WT
keratinocytes (Figures 3I and S3C). Taken together, these data
strongly suggest that the accelerated healing of 14-3-3z KO
wounds is dependent on sharply elevated signaling downstream
of ROCK at 14-3-3z KO wound margins compared with WT
(Figure 2F), which caused increased paracrine signaling to
dermal fibroblasts, enhanced ECM production, elevated
outside-in mechano-transduction signaling mediated by FAK
and Akt, and accelerated re-epithelialization.
14-3-3z in Inflammatory Cells DoesNot InfluenceWound
Healing
Inflammation plays a key role in wound healing by fighting infec-
tion and clearing tissue debris (Eming et al., 2007). To ascertain if
14-3-3z deficiency in the immune cell infiltrate of 14-3-3z KO
wounds has a role in accelerated healing, we generated bone
marrow chimeric mice as follows: WT bone marrow cells en-
grafted into WT mice as an engraftment control, 14-3-3z KO
bone marrow cells into WT mice, and conversely WT bone
marrow cells into 14-3-3zKOmice as test cohorts. After allowing
4 weeks for reconstitution of the immune system, we performed
incisional wounding on these mice and measured the widths of
wounds harvested at day 5 after wounding. Wound healing in
14-3-3z KO mice engrafted with WT bone marrow was signifi-
cantly accelerated compared with that in WT mice engrafted
with 14-3-3z KO bone marrow or WT mice engrafted with WT
bone marrow (Figure 4A). Engraftment was verified by flow cy-
tometry (Figures S4A and S4B), which also showed that 14-3-
3z KO inflammatory cells are recruited to wounds at comparable
rates to WT inflammatory cells (Figure S4B, skin panel). These
data strongly suggest that the 14-3-3z deficiency in the immune(E) Representative confocal immunofluorescence analysis of pFak (top six panels
single channel, green in merged) at day 7 WT and 14-3-3z KO wound margins. C
(F) Integrated density of pFak immunofluorescence at wound margins of day 7 W
(G) Widths (day 5) of 14-3-3z KO wounds topically treated daily with vehicle (VEH
(H)Col1a1mRNA expression relative to 18 s rRNA in dermal fibroblasts incubated
dead (KD) ROCK or conditionally activated ROCK, diluted 1:1 with fibroblast gro
(I)Col1a1mRNA expression relative to 18S rRNA in WT or 14-3-3z KO primary der
(Sv) or starved and stimulated (SS), WT or 14-3-3z KO primary keratinocytes, dil
See also Figure S3.
Developmesystem plays no role in the accelerated healing of 14-3-3z KO
wounds.
14-3-3z KO Dermal Fibroblasts Exhibit Impaired Matrix
Remodeling Capabilities
To determine why impaired collagen remodeling was observed
during the healing of 14-3-3z KO wounds compared with WT
(Figures 2C and S2C), we used primary dermal fibroblasts
derived from 14-3-3z KO mice and their WT littermates in an
in vitro collagen remodeling assay (Nobis et al., 2013; Timpson
et al., 2011). WT dermal fibroblasts embedded into a collagen
matrix rapidly remodeled the collagen fibers, resulting in a signif-
icant reduction in matrix size within 5 days, whereas 14-3-3z KO
dermal fibroblasts could not (Figure 4B). 14-3-3z KO fibroblasts
plated onto a collagen matrix exhibited more stress fibers than
WT dermal fibroblasts (Figure 4C) reminiscent of 14-3-3zKO ker-
atinocytes (Figures 2H and S2L), but also larger focal adhesions
that persisted upon serum starvation compared with WT dermal
fibroblasts (Figure 4C). However, total paxillin levels were similar
in dermal fibroblasts of both genotypes (Figure 1G; quantified in
Figure S1H). Live-cell imaging of dermal fibroblasts containing
paxillin labeled with eGFP revealed that focal adhesion number
and size were increased in 14-3-3z KO compared with WT
dermal fibroblasts (Movie S1; Figures 4D–4F). Dynamic regula-
tion of focal adhesions such that they are assembled and disas-
sembled in a coordinated fashion is essential to fibroblast
motility and their ECM remodeling functions (Calvo et al., 2013;
Maller et al., 2013). Accordingly, cell motility on a collagen
coated surface as determined by the movement of cells into a
scratch wound (Figures 4G, S4C, and S4D) was significantly
lower in 14-3-3z KO fibroblasts compared with WT fibroblasts.
Furthermore, dual live-cell imaging of GFP-labeled dermal fibro-
blasts with corresponding SHG imaging of 3D organotypic
collagen matrices in which the cells had been embedded re-
vealed that whereas WT cells exhibited an elongated, fibro-
blast-like morphology and actively interacted with the collagen
matrix (Movie S2; Figure 4H) consistent with good collagen re-
modeling capacity (Figure 4B), 14-3-3z KO dermal fibroblasts
exhibited a contracted morphology with blebbing, consistent
with hyper-activated ROCK signaling, did not interact with the
collagen matrix, and were relatively immotile (Movie S2; Fig-
ure 4H), consistent with poor ECM remodeling capacity (Fig-
ure 4B). Circularity analysis of cells in 3D organotypic collagen
matrices performed to establish a quantitative basis for cell
morphology revealed that 14-3-3z KO fibroblasts were approxi-
mately 40% less elongated that WT fibroblasts (Figure 4I) but,
interestingly, adopted an elongated morphology similar to that
of WT fibroblasts when incubated in 3D organotypic collagen
matrices containing the selective ROCK inhibitor Y-27632 (Movie: white in single channel, green in merged) and pAkt (bottom six panels: white in
K14 denotes epidermal layer. The scale bars represent 100 mm.
T and 14-3-3z KO wounds. N = 8.
) or ROCK inhibitor (Y-27632). N = 6.
for 8 hr with medium conditioned for 18 hr by keratinocytes expressing kinase-
wth medium. N = 3.
mal fibroblasts incubated for 8 hr with medium conditioned for 18 hr by starved
uted 1:1 with fibroblast growth medium. N = 3.
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Figure 4. 14-3-3z KO Dermal Fibroblasts Exhibit Reduced Matrix Remodeling Capabilities and Motility
(A) Wound widths (day 5) of WT or 14-3-3z KO mice that had been reconstituted ([) with WT or 14-3-3z KO bone marrow cells as indicated.
(B) Representative images of collagen matrices containing 0.8x106 WT or 14-3-3z KO fibroblasts on days 1, 5, and 11 of culture. Percentage contraction is
quantified. N = 3 matrices per condition.
(C) Immunofluorescence analysis of focal adhesions (paxillin [green]) with actin (red) in steady state, serum starved, and starved and stimulated 14-3-3z KO and
WT primary dermal fibroblasts. Arrowhead indicates a focal adhesion. The scale bar represents 50 mm.
(D) Number of eGFP-paxillin labeled focal adhesions per cell (N = 8–10) from live-cell images of starved or starved and stimulated WT or 14-3-3z KO dermal
fibroblasts.
(legend continued on next page)
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S2; Figure 4J). Tellingly, this effect of Y-27632 was dose
dependent.
These results show that 14-3-3z deficiency in dermal fibro-
blasts mediates aberrant focal adhesion dynamics associated
with a contracted morphology, reduced capacity to migrate on
collagen, and impaired ability to remodel 3D collagen matrices.
Collagen remodeling capacity andmotility are restored by selec-
tive ROCK inhibition, strongly suggesting that increased ROCK
activation in 14-3-3z KO fibroblasts is the cause of these
phenotypes.
Signaling Flux through the ROCK Pathway Is Also
Elevated in 14-3-3z KO Dermal Fibroblasts
Rho activity mediated by ROCK induces and stabilizes stress fi-
bers and focal adhesions, and Rho inhibition at the leading edge
is required for the focal adhesion dynamics essential for cell
motility (reviewed byBurridge andWennerberg, 2004).We there-
fore hypothesized that 14-3-3z deficiency may enhance
signaling downstream of ROCK in dermal fibroblasts in a manner
similar to that shown above in keratinocytes. Western analysis
showed that Mypt1 (particularly the 75 kDa isoform) (Olsen
et al., 2010) phosphorylated at ROCK target site Thr-696 (Fig-
ure 5A; quantified in Figure 5C), and Mlc2 di-phosphorylated at
ROCK target sites Thr18 and Ser19 (Figure 5B; quantified in Fig-
ure 5D) weremore abundant in 14-3-3zKO cells than inWT cells,
particularly under conditions in which the ROCK pathway is
activated.
These observations show that 14-3-3z deficiency causes
increased signal flux through the ROCK pathway in dermal fibro-
blasts and increased phosphorylation of ROCK target proteins.
Mypt1 Phosphorylation at Ser-909 Is Required for
Strong Association with 14-3-3z
To determine if 14-3-3z interacts with signaling proteins associ-
ated with the ROCK signaling pathway, we performed pull-down
assays using recombinant murine 14-3-3z-GST fusion protein on
glutathione Sepharose beads, incubated with whole-cell lysates
of dermal fibroblasts. Of all the Rho-ROCK signaling proteins
predicted to have putative 14-3-3 consensus binding sites (indi-
cated in red in Figure 5E) as identified by Scansite 3.0 (Obenauer
et al., 2003), onlyMypt1 interacted with 14-3-3z (Figure 5F) under
these conditions. Furthermore, in dermal fibroblasts that had
been starved and stimulated (Figure 5G) as well as in primary
WT keratinocytes (Figure 5H), endogenous Mypt1 co-immuno-
precipitated with 14-3-3z in the presence of phosphatase inhib-
itors but not in the presence of alkaline phosphatase (Figure 5G,
lane C16(P)), strongly suggesting that the interaction between 14-
3-3z and Mypt1 is physiologically relevant and dependent on(E) Area of eGFP-paxillin labeled focal adhesions per cell (N = 8–10) in live-cell im
(F) Still frames from live-cell movies of starved or stimulated WT or 14-3-3z K
adhesion. See also Movie S1.
(G) Relative wound densitymeasurements of in vitro scratchwound assays condu
experiments of eight scratch assays per genotype.
(H) Still frames from dual GFP fluorescence (green) and collagen SHG (magenta
collagen matrices. The scale bars represent 100 mm. See also Movie S2.
(I) Cell circularity of WT and 14-3-3z KO dermal fibroblasts cultured in collagenma
(J) Still frames from dual GFP fluorescence (green) and collagen SHG (magenta
collagen matrices, cultured with or without Y-27632 (0, 10, or 20 mM). The scale
See also Figure S4.
Developmephosphorylation. Interestingly, co-immunoprecipitation of
Mypt1 with 14-3-3z was not observed with another 14-3-3 anti-
body (G1-7) (Ramshaw et al., 2013) with lower selectivity for 14-
3-3z than for other isoforms (Figure 5G). Taken together with our
data showing increased Mlc2 phosphorylation in 14-3-3z KO
cells (Figures 2H, 5B, and 5D), these results show that 14-3-3z
strongly associates with Mypt1.
To determine which amino-acid residues were critical for
Mypt1’s association with 14-3-3z, we generated expression
constructs encoding FLAG-tagged versions of Mypt1 and
carrying S/A modifications at putative 14-3-3z binding sites,
overexpressed these in HEK293T cells and performed co-immu-
noprecipitation analysis with an anti-FLAG antibody. Although
14-3-3z was capable of associating with Mypt1S445A and
Mypt1S472A as readily as it could with WT Mypt1, its association
with Mypt1S909A and a version of Mypt1 in which all three serine
residues were changed to alanine (Mypt1SiiiA) was significantly
impaired (Figure 5I; quantified in histogram). We therefore
concluded that phosphorylation at Ser-909 is required for the
strong association of 14-3-3z with Mypt1.
Pharmacological Inhibition of 14-3-3 Function
Accelerates Wound Healing and Phenocopies 14-3-3z
Deficiency
The 14-3-3 proteins function as obligate dimers (Messaritou
et al., 2010). 14-3-3 dimerization and therefore function are abol-
ished by phosphorylation at Ser-58, which is located at the dimer
interface (Woodcock et al., 2010). We have recently reported the
rational design and validation of novel pharmacological inhibitors
of 14-3-3 that function by facilitating 14-3-3 phosphorylation at
the dimer interface (Woodcock et al., 2015). To determine if
14-3-3 inhibition in the skin phenocopies 14-3-3z deficiency
and accelerates wound re-epithelialization, we topically treated
WT and 14-3-3z KOmice with RB-11 at a dose previously shown
to inhibit 14-3-3 in vivo (Woodcock et al., 2015), for 7 days
following incisional wounding. 14-3-3 inhibition increased the
rate of re-epithelialization (Figure 6A), enhanced Mypt1 phos-
phorylation at wound margins (Figure 6B), and elevated collagen
production (Figure 6C) inWTmice, similar to that observed in 14-
3-3z KO wounds (Figure 2). Furthermore, WT dermal fibroblasts
cultured in the presence of RB-11, exhibited reduced collagen
remodeling capacity approaching that observed in 14-3-3z KO
dermal fibroblasts (Figures 6D and S5A). Live-cell images of
GFP-labeled WT dermal fibroblasts within 3D collagen organo-
typic matrices treated with RB-11 exhibited a contracted
morphology and interacted with the ECM and each other infre-
quently in a manner similar to 14-3-3z KO fibroblasts that had
been treated with RB-11 or vehicle (Movie S2). Circularityages of starved or stimulated WT or 14-3-3z KO dermal fibroblasts.
O dermal fibroblasts, expressing eGFP-paxillin. Arrowhead indicates a focal
cted onWTor 14-3-3zKOand dermal fibroblast cultures. Results are from three
) live-cell movies of GFP labeled WT and 14-3-3z KO dermal fibroblasts in 3D
trices. Data are from three fields containing several hundred cells per condition.
) live-cell movies of GFP labeled WT and 14-3-3z KO dermal fibroblasts in 3D
bars represent 100 mm. See also Movie S2.
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Figure 5. 14-3-3z Binds Mypt1 to Regulate Signal Flux Downstream of ROCK
(A and B) Western analysis of WT and 14-3-3z KO cultured dermal fibroblasts. Antibodies are indicated on the right. SS, starved for 24 hr and stimulated with
medium containing 10% serum for 1 hr; St, standard culture conditions; Sv, starved 24 hr in serum-free medium.
(C) Mean band densities of both the long (115 kDa) and short (75 kDa) forms of p(Thr-696)Mypt1 relative to a-tubulin and normalized to WT/Sv condition, derived
from the western analyses shown in (A) and repeats. N = 3.
(D) Mean band densities of pMlc2 relative to total Mlc and normalized to WT/St, derived from the western analyses shown in (B) and repeats. N = 3.
(E) RhoA/C-ROCK signaling pathway. Molecules with putative (Scansite 3.0) or published 14-3-3 binding sites are in red.
(legend continued on next page)
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Figure 6. Pharmacological Inhibition of 14-
3-3 Accelerates Wound Healing and Pheno-
copies 14-3-3z Deficiency
(A)Woundwidths (day 7) ofWT or 14-3-3zKOmice
treated with RB-11 or vehicle control.
(B) Confocal immunofluorescence analysis of
p(Thr-696)Mypt1 (green) in WT mice treated with
RB-11 or vehicle control. CK14 (red) delineates
epidermis. The scale bars represent 100 mm.
(C) Dual two-photon SHG and transmission mi-
croscopy (Trans; grayscale in merged) showing
collagen (Col; white in single channel, magenta in
merged) of H&E-stained sections of wound mar-
gins of WT and 14-3-3z KO mice treated with RB-
11 or vehicle. The scale bars represent 100 mm.
(D) Percentage contraction of collagen matrices
from Figure S5 over time. Measurements are
shown for WT cells (blue line), WT cells in RB-11
(10 mM, orange line), 14-3-3z KO cells (green line),
and 14-3-3z KO cells in RB-11 (10 mM, purple line).
Medium was replenished on day 5. N = 3 matrices
per condition.
(E) Cell circularity of WT and 14-3-3z KO dermal
fibroblasts cultured in collagen matrices with RB-
11 (10 mM) or vehicle. N = 3matrices per condition.
Images show single frames from live-cell videos
(Movie S2) of dual two-photon GFP-fluorescence
(green) and collagen SHG (magenta) analysis of
GFP-labeled WT and 14-3-3z KO dermal fibro-
blasts. The scale bars represent 100 mm.
See also Figure S5.analysis revealed thatWT dermal fibroblasts cultured in the pres-
ence of RB-11 exhibited a rounded morphology similar to that of
14-3-3z KO dermal fibroblasts (Figure 6E) and that treatment
with RB-11 caused no further change in the morphology of 14-
3-3z KO dermal fibroblasts, consistent with the observation
that RB-11 inhibited the ability of 14-3-3z to interact with
Mypt1 (Figures S5B and S5C).
Taken together, these results show that pharmacological inhi-
bition of 14-3-3 phenocopies 14-3-3z deficiency, increasing
signal flux through the ROCK pathway, impairing the ECM re-
modeling, and accelerating wound healing.(F) Western analysis (WB) of GST-14-3-3z Sepharose or GST-Sepharose pull-downs (PD) fromWT and 14-3
WB are on the left, and beads used for PD are on the right. Analysis of 10% of whole-cell extract (WCE) u
(G) Co-immunoprecipitation (IP) analysis of primary dermal fibroblast lysates with G1-7 anti-14-3-3 antibod
3z-selective commercial antibody C-16, with and without added phosphatase (C-16(P)). Input is 10% of th
(H) IP analysis of primary keratinocyte lysates with the 14-3-3z selective commercial antibody C-16.
(I) IP analysis of lysates derived from HEK293T cells expressing constructs encoding FLAG-tagged versions
or Mypt1 containing all three mutations (Mypt1SiiiA), with anti-FLAG antibody. IgG immunoprecipitation con
3-3z band densities from FLAG immunoprecipitation expressed relative to Mypt1 and normalized to WT.
Developmental Cell 35, 759–774,14-3-3z Is Upregulated in Chronic
Wounds and Downregulated in
Cutaneous SCCs
To determine if 14-3-3z-mediated regula-
tion of ROCK signaling has clinical
relevance, we performed confocal immu-
nofluorescence analysis of 14-3-3z in
histological samples of three different cate-
gories of patient wounds with long healingtimes (burn, hypertrophic scar, and diabetic ulcer) and
compared these results with those from normal skin. Area
coverage analysis of 14-3-3z immunofluorescence revealed
that diabetic ulcers and hypertrophic scars exhibited >2-fold
higher median levels of 14-3-3z compared with normal un-
wounded skin (Figures 7A and S6A). Whereas the majority of
burn biopsies expressed high levels of 14-3-3z compared with
normal skin, the difference was not statistically significant as a
proportion of burn samples had levels of 14-3-3z that were com-
parable with that in unwounded skin (Figure 7A). These data sug-
gest that long healing times may arise from increased levels of-3z KO dermal fibroblast lysates. Antibodies used for
sed in the PD experiment is also shown.
y (isoform non-selective; see Table S1) and the 14-3-
e WCE used per immunoprecipitation.
of WT Mypt1, Mypt1S445A, Mypt1S472A, Mypt1S909A,
trols are shown at the bottom. Histogram shows 14-
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Figure 7. 14-3-3z Is Differentially Regulated
in Chronic Wounds and Cutaneous SCC
(A) Representative immunofluorescence of 14-3-3z
(green) in normal human skin (n = 5) and patient
wound tissue together with area coverage analysis
quantifying 14-3-3z levels in wound tissue
compared with normal skin, shown as medians and
inter-quartile ranges. Burn, burn wound (n = 10);
Hyper. scar, hypertrophic scar (n = 13); Diab. ulcer,
diabetic ulcer (n = 10). The scale bar represents
100 mm.
(B and C) (B) Area coverage quantification of 14-3-
3z immunofluorescence (grayscale in monochrome,
green in merged) in normal margin skin and cuta-
neous SCCs from human patients (n = 21), shown as
medians and inter-quartile ranges. Representative
specimens are shown in (C). The scale bar repre-
sents 100 mm.
(D)Median cross-sectional area of tumors inWT and
14-3-3z KOmice (ten mice/genotype). Medians and
quartiles are shown. Representative images are
shown. The scale bar represents 1 cm.
(E) Schematic demonstrating how 14-3-3z regulates
the equilibrium between the phosphorylated (active)
and non-phosphorylated (inactive) versions of Mlc2
by indirectly regulating signal flux through ROCK
(dotted line).
See also Figure S6.14-3-3z, which likely results in attenuated ROCK signaling, and
that patients with these wounds may therefore benefit from ther-
apy to inhibit 14-3-3 to promote faster re-epithelialization.
Cutaneous SCCs exhibit enhanced mechano-reciprocity
characterized by progressively elevated ECM stiffness and
ROCK pathway activation (Ibbetson et al., 2013; Samuel et al.,
2011a; Samuel and Olson, 2011). To determine the status of
14-3-3z-mediated negative regulation of ROCK signaling in cuta-
neous SCCs, we performed immunofluorescence analysis of 14-
3-3z in 21 human SCCs and normal margin skin that we have
previously characterized in respect of ROCK activation status
and ECM protein levels (Ibbetson et al., 2013). 14-3-3z is down-
regulated in a large majority of cutaneous SCCs (Figures 7B and
7C), suggesting that signaling flux downstream of ROCK is no
longer moderated by 14-3-3z in SCCs, consistent with increased770 Developmental Cell 35, 759–774, December 21, 2015 ª2015 Elsevier Inc.MYPT phosphorylation and elevated
collagen and other ECM proteins found in
these SCCs (Ibbetson et al., 2013).
To determine the effect of mechano-
reciprocity on tumor growth, we next
examined tumor size in cohorts of 14-3-
3z KO and WT mice placed on the two-
stage chemical carcinogenesis protocol.
Whereas syngeneic papillomas of squa-
mous cell origin arose in both 14-3-3z KO
and WT mice in similar numbers, 14-3-3z
KO mice exhibited a significantly larger
median papilloma size than WT mice at
30 weeks (Figure 7D) and increased
collagen in the tumor stroma (Figure S6B).
Taken together with our observations onwound healing in 14-3-3z-deficient mice and mice in which 14-
3-3 has been pharmacologically inhibited, these observations
strongly suggest that 14-3-3z-mediated moderation of me-
chano-reciprocity has an important function in maintaining
epidermal homeostasis, by moderating the speed of wound
healing and suppressing the growth of epidermal tumors.
DISCUSSION
Re-establishment and remodeling of dermal ECM is a key
outcome of wound healing (Li et al., 2007). Given the ECM’s
role in extra-cellular force generation and because we had previ-
ously shown that the ROCK signaling pathway regulates dermal
ECM production, we reasoned that important negative regula-
tory mechanisms identified in this non-transformed system
may have useful implications for diseases of aberrant tissue ho-
meostasis, including cancer.
Signaling through ROCK is enhanced at wound margins
throughout healing, resulting in increased production and
impaired remodeling of collagen, and elevated periostin and te-
nascin-C, key ECM proteins whose functions include stiffening
the matrix and forming the substratum on which re-epithelializa-
tion can occur. However, flux through the ROCK pathway is
moderated by 14-3-3z, which alone of all its family members is
upregulated at wound margins (Figures 1D and 1E), and whose
binding of Mypt1 via pSer-909 is associated with de-phosphor-
ylation and inactivation of the regulatory myosin light chain
(Mlc2). However, residual 14-3-3z binding to Mypt1S909A and
Mypt1SiiiA forms of Mypt1 (Figure 5H) suggests that phosphory-
lation at Serine-909 is not the sole regulator of 14-3-3z binding.
Indeed, 14-3-3 proteins usually require paired target sites for
robust association with client proteins. Because only one of
three putative 14-3-3 binding sites on Mypt1 is indispensable
for 14-3-3z binding, the second site is likely either a non-canon-
ical phospho-amino acid or a hybrid prenyl binding site similar to
that recently reported (Riou et al., 2013).
Mlc2 exists in equilibrium between the (active) version pp(Thr-
18/Ser-19) phosphorylated by ROCK and the (inactive) non-
phosphorylated version. Because the equilibrium between the
active and inactive versions of Mlc2 controls actomyosin
contractility, Mlc2 inactivation by 14-3-3z via Mypt1 reduces
actomyosin contractility and the ability of cells to act
mechano-reciprocally. 14-3-3z therefore negatively regulates
mechano-reciprocity, and its mRNA and protein levels are
elevated to accomplish this function, consistent with a recent
report of transcriptional regulation of YWHAZ gene expression
(Kasinski et al., 2014).
14-3-3b has been proposed to dissociate Mypt1 from
myosin II and inhibit dephosphorylation of Mlc2 (Koga and
Ikebe, 2008). This contrasts with our data that Mlc2 phosphor-
ylation is elevated when 14-3-3z is absent (Figures 2I and 2H in
keratinocytes and Figure 5B in dermal fibroblasts). It follows
that the cellular context greatly influences 14-3-3 function, or
that 14-3-3z and 14-3-3b have opposing isoform-specific func-
tions. Interestingly, we did not observe co-regulation of these
isoforms (Figures S1C and S1F). Although Ser-472 on MYPT1
was reported to be essential for binding 14-3-3b in cell lines
(Koga and Ikebe, 2008), we show that phosphorylation at
Ser-909 regulates 14-3-3z binding and that Ser-472 is dispens-
able for 14-3-3z binding to Mypt1 in the skin (Figure 5H).
Further work remains to identify the kinase(s) regulating
Mypt1 phosphorylation at Ser-909 in this context and deter-
mine how 14-3-3z promotes Mypt1 activity. However, our
observation that the inactivating phosphorylation of Mypt1 at
Thr-696 by ROCK is increased in 14-3-3z KO or RB-11 treated
tissues and cells (Figures 2F, 2G, 5A, and 6B) strongly suggests
that Mypt1 is rendered more susceptible to phosphorylation by
ROCK when 14-3-3z is absent or inhibited, which is also
consistent with increased active pMlc2 under these conditions
(Figures 2H, 2I, 5B, and 5D). Our data raise the possibility that
upon binding Mypt1, 14-3-3z may sterically hinder the interac-
tion with ROCK (a large protein), thereby protecting Mypt1 from
phosphorylation and inactivation, while having no effect on its
interaction with Mlc2 (a small protein).DevelopmeReconstituting 14-3-3z KO mice with WT bone marrow failed
to return wound healing speed and tissue morphology to normal
(Figure 4A), showing that 14-3-3z’s modulation of healing is inde-
pendent of the immune system and that the well-known func-
tions of the immune system in wound healing are likely not
conducted through 14-3-3z.
We propose that keratinocytes in which signaling downstream
of ROCK is enhanced by deletion or inhibition of 14-3-3z or by
direct conditional ROCK activation signal to dermal fibroblasts
to increase their ECM production (Figures 3H, 3I, S3B, and
S3C), consistent with our previous observations in vivo (Ibbetson
et al., 2013; Samuel et al., 2011a). Furthermore, when signaling
downstream of ROCK is enhanced in fibroblasts by the same
means, the motility of dermal fibroblasts is compromised (Fig-
ures 4G, S4C, and S4D; Movie S2) by larger and stable focal
adhesions (Movie S1; Figures 4C and 4E), and they are no longer
able to remodel collagen in vitro (Figures 4B, 6D, and S5A) or at
wound margins in vivo (Figures 2A–2C and 6C), further contrib-
uting to increased dermal stiffness. Therefore, loss of 14-3-3z
activity and increased skin stiffness leads tomechano-reciprocal
activation of the integrin/FAK/PI3K/AKT mechano-transduc-
tion pathway (Figures 3D–3F). We and others have shown that
across many tissue types, increased ECM production elevates
stiffness and promotes cell proliferation through this mechano-
transduction pathway (Levental et al., 2009; Samuel et al.,
2011a), providing a mechanism for rapid wound healing under
these conditions.
That 14-3-3z KO and RB-11 treated WT mice exhibited com-
parable wound healing times and that treatment of 14-3-3z KO
wounds with RB-11 did not accelerate wound healing (Figure 6A)
constitute strong circumstantial evidence that acceleration of
wound healing by RB-11 results predominantly from the inhibi-
tion of 14-3-3z. Together with our observation that the 14-3-3z
isoform alone is upregulated in wounds, these data suggest a
non-redundant function of 14-3-3z in moderating signaling flux
through the ROCK pathway and regulating mechano-reciprocity
in the skin.
This raises the question as to why a mechanism to moderate
re-epithelialization is required, when it would appear that
speedy wound healing would have the significant advantages
of rapidly re-establishing skin barrier function and minimizing
the risk of infection. However, our data that skin tumor growth
is accelerated in 14-3-3z KO mice compared with WT mice
(Figure 7D) and that 14-3-3z is downregulated in human cuta-
neous SCCs (Figure 7B) lead us to conclude that 14-3-3z has
a role in maintaining mechano-reciprocity within acceptable
boundaries such that re-epithelialization is promoted and tumor
growth is not. We propose that in chronic wounds, overexpres-
sion of 14-3-3z leads to aberrant and persistent downregulation
of signaling downstream of ROCK, resulting in a scant and
pliant ECM that is incapable of initiating the robust mechanical
signal required for re-epithelialization, whereas in cutaneous
SCCs, 14-3-3z deficiency leads to aberrant and elevated
signaling downstream of ROCK, causing increased production
of collagen and other molecules that stiffen the matrix and pro-
mote keratinocyte proliferation and tumor progression (summa-
rized in Figure 7E). 14-3-3z therefore maintains mitogenic
mechano-transduction signaling in the skin between healthy
boundaries. The need for this balance is illustrated by Marjolin’sntal Cell 35, 759–774, December 21, 2015 ª2015 Elsevier Inc. 771
ulcer, a form of cutaneous SCC that arises in scar tissue (Saaiq
and Ashraf, 2014). The observation that 14-3-3z is downregu-
lated in cutaneous SCC contrasts with previous reports that
14-3-3z expression is elevated in some other cancers and
14-3-3 has in fact has been proposed as a potential cancer
target (Matta et al., 2012). We would therefore sound a note
of caution because of the potential pleiotropy of 14-3-3z,
whose inhibition to target other cancers may promote progres-
sion of cutaneous SCCs.
EXPERIMENTAL PROCEDURES
Mice
All procedures were approved by the relevant institutional animal ethics com-
mittees. 14-3-3z-deficient (Cheah et al., 2012) and K14-ROCK:ER and K14-
KD:ER (Samuel et al., 2009a) mice have been previously described.
Incisional Wounding
Incisional wounding was performed as we have previously described (Lees
et al., 2013). Daily topical treatments per mouse were as follows: RB-11,
10 mg (25 nmol); Y-27632, 25 mg; and 4HT, 50 mg. Micewere euthanized at rele-
vant time points (2, 5, 7, 14, and 21 days). One wound, with a 1 cmmargin, was
fixed in 4% formalin O/N at 4C. Fixed wounds were bisected at the center,
processed, and embedded in paraffin. Wound widths were measured on
images of H&E-stained sections acquired with NDPView slide scanning and
image quantification software. Remaining wounds were processed for molec-
ular analyses.
Chemical Carcinogenesis and Epidermal Hyper-proliferation
Chemical carcinogenesis was performed as we have previously described
(Samuel et al., 2011a). Hyper-proliferation was induced with TPA alone.
Cells
Primary murine dermal fibroblasts and keratinocytes were derived as
described previously (Calvo et al., 2013; Samuel et al., 2009a). Dermal fibro-
blasts were transfected with plasmid encoding eGFP-paxillin (Addgene) using
Lipofectamine 2000 (Thermo Fisher Scientific) according to themanufacturer’s
instructions, or infected with retrovirus encoding eGFP (LMP-puro-eGFP)
(Dickins et al., 2005) or mCherry (LMP-puro-mCherry) for live-cell imaging.
Fibroblasts were starved for 24 hr in serum-free DMEM to minimize Rho-
ROCK signaling and stimulated with serum-containing medium supplemented
with epidermal growth factor (EGF, 50 ng/ml) for 10 min to 2 hr to stimulate
Rho-ROCK signaling (time course in Figure S2K).
Histological and Immunohistological Analyses
Histology and immunohistology were performed as previously described (Ib-
betson et al., 2013; Samuel et al., 2009b, 2011a, 2011b). Antigen retrieval
buffer, method, and antibody dilutions appear in Table S1. Histology slides
were imaged using a Hamamatsu Nanozoomer NDP slide scanner (Hama-
matsu Photonics) and Digital Slide Server (Slidepath) software. Transmission
and SHG images were acquired simultaneously using an LSM 710 two-photon
excitationmicroscope (Zeiss). Immunofluorescence imageswere acquired us-
ing an LSM 700 confocal microscope (Zeiss).
In all images of sectioned wounds, we have adhered to the following
convention: dotted lines indicate wound edges (Figure S2A). Wound margin
tissue is to the left of each dotted line.
Bone Marrow Chimeric Mice
Recipient female BALB/c mice (R8 wk old) were given 750 cGy g-irradiation
from a linear accelerator. One day post-irradiation, mice were engrafted by
tail vein injection with female bone marrow cells (WT into WT recipients as irra-
diation control; KO into WT or WT into KO recipients) using the CD45.1 and
CD45.2 to distinguish donor from recipient cells at endpoint. Cells from one
donor mouse repopulated three recipients. After 4 weeks in sterile conditions,
mice were wounded.772 Developmental Cell 35, 759–774, December 21, 2015 ª2015 ElsHuman Tissue Samples
For human wound and cutaneous SCC samples, informed consent was ob-
tained from patients. Study protocols conformed to ethical guidelines of the
1975 Declaration of Helsinki, reflected in approvals by the Health Service Hu-
man Research Ethics Committee and Central Northern Adelaide Health Ser-
vice Ethics of Human Research Committee approvals HREC/12/TQEHLMH/
107, CNAH 11-CHREC-F007, and RAH 120113.
Statistical Analyses
Box-and-whisker plots show medians and quartiles or inter-quartile ranges of
non-parametric data, with p values calculated by either the Kruskal-Wallis
(three or more groups) or Mann-Whitney (two groups) test with Dunnet’s
post hoc test. Histograms and line graphs showmeans and SEs of data exhib-
iting a normal distribution and were analyzed using Student’s t test or ANOVA
with Tukey’s post-test. P < 0.05 was used as the significance cutoff.
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